Expo Capital Management
Latest statistics and disclosures from Expo Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Medicis Pharmaceutical Corporation, Endo Pharmaceuticals, Volcano Corporation, CNC, Watson Pharmaceuticals, and represent 26.23% of Expo Capital Management's stock portfolio.
- Added to shares of these 10 stocks: Endo Pharmaceuticals (+$27M), Volcano Corporation (+$26M), Watson Pharmaceuticals (+$24M), Sirona Dental Systems (+$23M), Qiagen (+$21M), Thoratec Corporation (+$19M), MOH (+$19M), Alere (+$19M), VCA Antech (+$19M), Salix Pharmaceuticals (+$18M).
- Started 14 new stock positions in Qiagen, WellCare Health Plans, Endo Pharmaceuticals, Volcano Corporation, Thoratec Corporation, Watson Pharmaceuticals, Gen-Probe Incorporated, Salix Pharmaceuticals, VCA Antech, RVTY. MOH, Sirona Dental Systems, WAT, Alere.
- Reduced shares in these 10 stocks: , Shire (-$23M), MDRX (-$22M), Mylan (-$22M), Hill-Rom Holdings (-$20M), BSX (-$19M), BMRN (-$18M), Cepheid (-$13M), UTHR (-$9.4M), HOLX (-$9.2M).
- Sold out of its positions in MDRX, BMRN, BSX, Hill-Rom Holdings, Mylan, Shire, Varian Medical Systems.
- Expo Capital Management was a net buyer of stock by $88M.
- Expo Capital Management has $524M in assets under management (AUM), dropping by 28.53%.
- Central Index Key (CIK): 0001426581
Portfolio Holdings for Expo Capital Management
Expo Capital Management holds 25 positions in its portfolio as reported in the March 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Medicis Pharmaceutical Corporation | 6.9 | $36M | +60% | 960k | 37.59 |
|
| Endo Pharmaceuticals | 5.2 | $27M | NEW | 700k | 38.73 |
|
| Volcano Corporation | 5.0 | $26M | NEW | 925k | 28.38 |
|
| Centene Corporation (CNC) | 4.7 | $25M | -25% | 500k | 48.97 |
|
| Watson Pharmaceuticals | 4.5 | $24M | NEW | 350k | 67.06 |
|
| Sirona Dental Systems | 4.4 | $23M | NEW | 450k | 51.54 |
|
| Cepheid | 4.2 | $22M | -36% | 525k | 41.83 |
|
| Brookdale Senior Living (BKD) | 4.1 | $22M | -20% | 1.2M | 18.72 |
|
| Qiagen | 4.0 | $21M | NEW | 1.4M | 15.57 |
|
| Onyx Pharmaceuticals | 4.0 | $21M | +57% | 550k | 37.68 |
|
| Cubist Pharmaceuticals | 3.9 | $21M | -29% | 475k | 43.25 |
|
| Hologic (HOLX) | 3.8 | $20M | -31% | 925k | 21.55 |
|
| Thoratec Corporation | 3.7 | $19M | NEW | 575k | 33.71 |
|
| Molina Healthcare (MOH) | 3.7 | $19M | NEW | 575k | 33.63 |
|
| Allergan | 3.6 | $19M | -27% | 200k | 95.43 |
|
| Alere | 3.6 | $19M | NEW | 725k | 26.01 |
|
| VCA Antech | 3.5 | $19M | NEW | 800k | 23.21 |
|
| Warner Chilcott Plc - | 3.5 | $19M | -12% | 1.1M | 16.81 |
|
| Salix Pharmaceuticals | 3.5 | $18M | NEW | 350k | 52.50 |
|
| Gen-Probe Incorporated | 3.5 | $18M | NEW | 275k | 66.41 |
|
| WellCare Health Plans | 3.4 | $18M | NEW | 250k | 71.88 |
|
| PerkinElmer (RVTY) | 3.4 | $18M | NEW | 650k | 27.66 |
|
| PSS World Medical | 3.4 | $18M | -30% | 700k | 25.34 |
|
| United Therapeutics Corporation (UTHR) | 3.4 | $18M | -34% | 375k | 47.13 |
|
| Waters Corporation (WAT) | 3.0 | $16M | NEW | 170k | 92.66 |
|
Past Filings by Expo Capital Management
SEC 13F filings are viewable for Expo Capital Management going back to 2010
- Expo Capital Management 2012 Q1 filed May 14, 2012
- Expo Capital Management 2011 Q4 filed Feb. 14, 2012
- Expo Capital Management 2011 Q3 filed Nov. 14, 2011
- Expo Capital Management 2011 Q2 filed Aug. 12, 2011
- Expo Capital Management 2011 Q1 filed May 13, 2011
- Expo Capital Management 2010 Q4 filed Feb. 15, 2011